Method for preventing and treating arthritis, osteo-traumatic pain, and neuralgias with trimebutine

• US 6,353,024 B1
• Filed: 01/24/2000
• Issued: 03/05/2002
• Est. Priority Date: 12/23/1999
• Status: Expired due to Fees

• Current Assignee: Warner-Lambert Company (Pfizer Inc.)
• Original Assignee: Warner-Lambert Company (Pfizer Inc.)
• Inventors: Roman, François, Grouhel, Agnès, Hamon, Jacques, Brunelle, Gilles
• Primary Examiner(s): Jarvis, William R. A.
• Application Number:
  US09/490,093
• Time in Patent Office: 771 Days
• Field of Search: 514/534
• US Class Current: 514/534
• CPC Class Codes: A61K 31/24 having an amino or nitro group
• CPC Class Codes: A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

The invention relates to the use of trimebutine [2-dimethylamino-2-phenylbutyl-3,4,5-trimethoxy-benzoate hydrogen maleate] or its corresponding stereoisomers for the preparation of a medicament to prevent and/or treat arthritis, osteo-traumatic pain, and neuralgias.

Claims

1. A method for preventing or treating arthritis, comprising administering to a patient in need thereof a pharmaceutical composition containing trimebutine, or a corresponding stereoisomer thereof, and a pharmaceutically acceptable carrier or excipient.

2. A method for preventing or treating osteo-traumatic pain, comprising administering to a patient in need thereof a pharmaceutical composition containing trimebutine, or a corresponding stereoisomer thereof, and a pharmaceutically acceptable carrier or excipient.

3. A method for preventing or treating neuralgias, comprising administering to a patient in need thereof a pharmaceutical composition containing trimebutine, or a corresponding stereoisomer thereof, and a pharmaceutically acceptable carrier or excipient.

4. A method for preventing or treating post-herpetic neuralgia, comprising administering to a patient in need thereof a pharmaceutical composition containing trimebutine, or a corresponding stereoisomer thereof, and a pharmaceutically acceptable carrier or excipient.